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Introduction
The C. elegans embryo develops rapidly with an invariant, fully
described lineage (Sulston et al., 1983), allowing determination
of defined gene expression states in each cell of the developing
embryo. As a first step toward this goal, we previously
measured temporal profiles of transcript abundance during
development with small cohorts of staged whole embryos
(Baugh et al., 2003). Because whole embryos are used,
expression in different lineages is integrated in the
measurement. However, the phenotypes of previously
described mutants offer a genetic approach with which to
dissect lineage-specific patterns of gene expression from
whole-embryo data.
Each of the six founder blastomeres gives rise to different
cell types by characteristic patterns of cell division (lineages)
(Sulston et al., 1983). Founder blastomere fates are specified
by a variety of spatially and temporally restricted maternal
gene activities. In addition, the embryo contains a global
anteroposterior (AP) patterning system that differentially
specifies the daughters of blastomeres dividing on the AP axis
(Kaletta et al., 1997; Lin et al., 1998). When gastrulation
commences at the 26-cell stage, all of the founder blastomeres
have been born and tissue identity begins to be specified, as
indicated by the initial expression of cell fate-specific genes,
whose functions are required for the development of specific
cell types, and increasing resistance of the embryo to cell fate
transformations induced by ectopic expression of such genes
(Gilleard, 2001; Zhu, 1998). It has been noted that although
such fate-specific genes are expressed in multiple lineages
(most tissues being polyclonal), the cells expressing them are
born at about the same time and in regional domains as if in
creation of a tissue or organ primordium (Labouesse and
Mango, 1999). From work on the C. elegans pharynx it is clear
that organ identity genes control autonomous organ-specific
genetic networks (Gaudet and Mango, 2002). However, it
remains to be determined how the lineage-based mechanisms
in the early embryo work together with the global AP
patterning system to pattern tissue and organ identity gene
expression, thus causally relating the maternal genetic network
that patterns the early embryo with the zygotic networks that
pattern later developmental structures.
The fate of the C and D founder blastomeres, the somatic
descendants of P2, is specified by the Caudal-like homeobox
gene pal-1. Maternal PAL-1 activity is temporally and spatially
targeted to the C and D founder blastomeres by first restricting
translation of maternal pal-1 mRNA to the descendants of the
posterior blastomere P1 (EMS and P2) and then by restricting
the activity of the translated protein to the somatic descendants
of P2 (C and D) (Hunter and Kenyon, 1996). The KH domain
protein MEX-3 is required to restrict translation of maternal
Maternal and zygotic activities of the homeodomain
protein PAL-1 specify the identity and maintain the
development of the multipotent C blastomere lineage in the
C. elegans embryo. To identify PAL-1 regulatory target
genes, we used microarrays to compare transcript
abundance in wild-type embryos with mutant embryos
lacking a C blastomere and to mutant embryos with extra
C blastomeres. pal-1-dependent C-lineage expression was
verified for select candidate target genes by reporter gene
analysis, though many of the target genes are expressed in
additional lineages as well. The set of validated target genes
includes 12 transcription factors, an uncharacterized
wingless ligand and five uncharacterized genes. Phenotypic
analysis demonstrates that the identified PAL-1 target
genes affect specification, differentiation and
morphogenesis of C-lineage cells. In particular, we show
that cell fate-specific genes (or tissue identity genes) and a
posterior HOX gene are activated in lineage-specific
fashion. Transcription of targets is initiated in four
temporal phases, which together with their spatial
expression patterns leads to a model of the regulatory
network specified by PAL-1.
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pal-1 mRNA to the posterior blastomeres at the four-cell stage
(EMS and P2) (Draper et al., 1996; Huang et al., 2002; Hunter
and Kenyon, 1996), while the bZIP transcription factor SKN-
1 blocks PAL-1 function in EMS, and the zinc-finger protein
PIE-1 maintains the germline blastomeres P2 and P3 in a
transcriptionally quiescent state so that PAL-1 activity is
restricted to their somatic descendants, C and D (Bowerman et
al., 1993; Hunter and Kenyon, 1996; Mello et al., 1996;
Seydoux et al., 1996).
The C lineage gives rise primarily to muscle and epidermis
but also two neuronal cells and a cell death (Sulston et al.,
1983). In the absence of maternal PAL-1 activity, the C and D
blastomeres fail to develop in any discernible way, while
ectopic PAL-1 activity causes other blastomeres to produce
muscle, epidermal and neuronal cells by a C-like lineage
(Draper et al., 1996; Hunter and Kenyon, 1996). Although
other somatic lineages also give rise to muscle and epidermal
cells, the lack of discernable C cell fates in the absence of
maternal PAL-1 function (Hunter and Kenyon, 1996), indicates
that PAL-1 activates cell fate specification factors (tissue
identity genes) in the C lineage.
To learn how maternal PAL-1 activity leads to the patterned
specification of multiple cell fates within a single blastomere
lineage, we aim to identify the genes directly and indirectly
activated by PAL-1 and determine their loss-of-function
phenotypes and regulatory interactions. To identify genes
expressed in the C lineage by microarray we have used pie-1
and mex-3 mutations, as well as skn-1 RNAi, to produce
embryos that either lack a C blastomere or that contain almost
exclusively C-like blastomeres. Our results are verified by
reporter gene analysis and complemented by phenotypic
analysis of PAL-1 targets, and a model for the regulatory
network specified by PAL is presented.
Materials and methods
Microarray sample preparation
Wild-type samples were prepared and described previously (Baugh et
al., 2003) but re-hybridized here to a different microarray. Strains
JJ532 [pie-1(zu154) unc-25(e156)/qC1[dpy-19(e1259) glp-1(q239)];
III] and JJ518 [mex-3(zu155) dpy-5(e61)/hT1; I] were grown at 15°C
either on E. coli OP50 or on HT115 (for RNAi), and Unc and Dpy
adults were respectively picked and cut for embryo collection.
Embryo collection and staging was as described (Baugh et al., 2003)
except that embryos were washed in 10 mM NaCl as opposed to water
and aged in the lids of 0.6 ml tubes rather than on microscope slides.
RNA was extracted and amplified as described (Baugh et al., 2001);
for protocol see http://mcb.harvard.edu/hunter/Protocols/protocols.
htm.
Microarray hybridization and data reduction
Biotinylated, amplified RNA (1 µg) was hybridized to the Affymetrix
C. elegans microarray as described (Baugh et al., 2003). Array data
were quantile normalized and reduced by the robust multi-chip
average algorithm (RMA) (Irizarry et al., 2003), using the
Bioconductor Affy package (version 1.0, www.bioconductor.org) for
the R statistics software (version 1.5.0, www.r-project.org). All
expression levels reported here were back-transformed to the linear
scale, i.e. reported values are 2(RMA). All raw data have been submitted
to the Gene Expression Omnibus database, Accession Number
GSE2180, and averaged data and analysis are available in the
supplementary material.
Clustering of gene expression profiles
Clusters were generated by a modified version of the QT clustering
algorithm (Heyer et al., 1999). This algorithm assembles a series of
clusters ordered by size with a defined limit on the largest pair-wise
distance allowed between any two profiles in a cluster. Distance
between profiles is measured as 1-R, where R is the Pearson
correlation coefficient. Although we limited this distance to 0.3, some
genes are included in clusters simply by chance. To reduce the
spurious inclusion of these genes in the final clusters, we
systematically re-sampled our data (100 times) with two forms of
synthetic noise added at each reiteration to generate an Ravg. Noise
was added to log2 scale RMA expression data, and was generated by
a two-component model consisting of an additive Gaussian
background with standard deviation 0.2, and a multiplicative Gaussian
sampling error with a standard deviation of 0.05. Simulated data were
floored at 1 RMA unit. Graphs plotting average expression for each
cluster, and the cluster to which each gene belongs can be found in
Fig. S1 and Data S1, S2 in supplementary material.
ANOVA
Analysis of variance (ANOVA) was performed by using a
randomization test to assess differences in expression among
genotypes at each time point. Tests were performed to assess for each
gene, overall variation among all three genotypes at each time point,
and variation between each of the three possible pairs of genotypes at
each time point. All statistical tests were performed on the log2 scale
data. Data for the pie-1(zu154) and pie-1(zu154); pal-1(RNAi)
genotypes were pooled to form a single group, denoted ‘pm’. Sample
labels were randomly shuffled 100 times, and for each shuffling, at
each time point, a null distribution of F-statistics were computed
among all three genotypes, and between each of the three pair-wise
combinations of genotypes at each time point [N2 versus mex-
3(zu155); skn-1(RNAi), N2 versus pm, and mex-3(zu155); skn-
1(RNAi) versus pm). P-values for differential expression among
groups were determined by referring the F-statistics from the observed
data to the null distribution arising from the random permutations. P-
values are not adjusted for multiple testing. The total number of
statistical tests per gene was 40 (10 time points with three pair-wise
comparisons and 1 overall comparison).
Target scoring
Clustering, correlation to known target genes and ANOVA were used
to score the PAL-1 target potential of each gene. Only genes with
maximum expression over time and genotype greater than the median
of all genes over time and genotype (transcript abundance of thirteen
RMA units) were considered as potential targets. Clusters 24, 50, 60,
140, 187, 141, 168, 85, 105, 130, 131, 144, 177, 195 and 88 were
selected as potential target clusters. Because our selection of pal-1
target clusters was subjective, each gene belonging to one of these
clusters was given a target score of only 1. We also leveraged our
limited prior knowledge to give genes a target score of 1 if they were
either one of the ten best correlated with vab-7 over time and genotype
or one of the 100 best correlated with cwn-1. vab-7 and cwn-1 had
been validated as target genes and are both expressed specifically in
the C lineage. The decision to include the 10 and 100 best correlated
genes for each was based on inspection of expression patterns.
The most rigorous approach was model-based and quantitative
ANOVA, which was used to assign a target score of 1-5, depending
on the P-value assigned to each gene at each time point for the
observed differences in expression between the three genotypes. For
each gene at each time point it was also determined if it was higher
in mex-3(zu155); skn-1(RNAi) than wild type and lower in pie-
1(zu154) than wild type. Genes with a P-value less than a given cut-
off and appropriate differences between genotypes were noted. With
this information, a target score was generated for each gene in two
ways and the maximum was kept. The first relies on the gene
satisfying both criteria in a pair of adjacent time points. Genes with
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a P-value below 10–2 for two adjacent time points were given a score
of 1, those below 10–3 were given a score of 2, those below 10–4 were
given a score of 3, those below 10–5 were given a score of 4, and those
below 10–6 were given a score of 5. The adjacency requirement
excludes late genes that show differences between genotypes in only
the last time point, and so the second target score requires the gene
to satisfy both criteria in only a single time point. Genes with a P-
value below 10–4 were given a score of one, those below 10–5 were
given a score of two, and those below 10–6 were given a score of three.
A nominal P-value of 10–4 (or 10–2 twice) with ~10,000 genes
considered at ten time points with two models (pair of adjacent time
points and single time point) should result in about 20 false positives;
however, the actual number of false positives should be less given the
additional requirement that the genotypes differ in specific ways.
To assign each gene a final target score the max of the ANOVA-
based models is added to the score from cluster analysis (1 or 0) and
correlation to known targets (1 or 0) producing a maximum score of
7. The target score therefore relies heavily on the ANOVA analysis,
with a score of 7 indicating that the gene is in a potential target cluster,
correlates well with either of the known targets, and has a P-value
below 10–6 in a pair of adjacent time points. By contrast, genes with
a score of 1 are either in a potential target cluster or well correlated
with a known target or have a minimally sufficient P-value.
Reporter analysis
Reporter constructs were made by PCR (Hobert, 2002). 5′ genomic
sequence, either 5 kb or up to the next gene, was used as promoter.
YFP was from pPD132.112, which includes C. elegans introns, a
nuclear localization signal and the unc-54 3′UTR; for additional
information see http://www.ciwemb.edu/pages/firelab.html (Fire et
al., 1990). Either 4 kb from pRF4 containing a dominant rol-6 (Mello
et al., 1991) or a 2.2 kb sequence unc-119 rescue sequence from
pDPMM051 (Maduro and Pilgrim, 1995) was included in the final
PCR construct as co-transformation marker. The vab-7 reporter
(HC14) was made by ligating a 5 kb AgeI/PstI GFP fragment from
pPD104.53 (Fire et al., 1990) to a 14 kb AgeI/PstI digestion pJA15
(Ahringer, 1996) to produce pHC16. JK3363 (Mathies et al., 2003)
was used rather than our hnd-1 reporter, as our reporter was too dim
to score. Either N2 or CB4845 [unc-119(e2498)] was injected with
PCR product diluted 10-fold in water as described (Mello et al., 1991);
rol-6 plasmid (pRF4) was co-injected at 50 ng/µl where rol-6 was
used as co-transformation marker, including HC14. Stable
extrachromosomal lines were used for initial reporter analysis, and
select reporters were chosen for chromosomal integration by gamma
irradiation as described (Inoue et al., 2002). Table S1 in the
supplementary material provides strain names and oligonucleotide
sequences used.
RNAi
Hairpin RNAi feeding vectors were made as described (Winston et
al., 2002) for pal-1, mex-3 and skn-1, and transformed into E. coli
HT115; for protocol see http://mcb.harvard.edu/hunter/Protocols/
protocols.htm. JJ532 was grown on both OP50 and HT115 expressing
double-stranded pal-1 RNA, but no differences were detected by
microarray (data not shown) and the data were merged. JJ518 was
only grown on HT115 expressing double-stranded skn-1 RNA. For
the reporter assay, in addition to being grown on RNAi food, worms
were soaked in double-stranded RNA as described (Maeda et al.,
2001) (Table 1).
3D imaging
Four-cell embryos were collected from cut mothers by mouth pipette
and mounted on 2.0% agarose pads. An Olympus IX70 microscope
equipped with Nomarski and fluorescence optics and DeltaVision
Spectris software was used to image embryos 210 minutes after the
four-cell stage (22°C). Generally, about 40 optical sections along the
z-axis (ranging from 0.7 to 1.2 µm) were gathered at exposure times
ranging from 0.2 to 1.3 seconds. Sections were rendered into three-
dimensional images with softWorx Volume Viewer, and projections
were generated from maximum intensity voxels every 12° around the
Fig. 1. Use of homeotic
mutants to deconvolve
lineage-specific
expression from
transcript profiles.
Wild-type and mutant
embryos were staged in
small cohorts by
morphology at the four-
cell stage and collected
in replicate at the ten
time points indicated by
black dots in A. The
complete lineage
through the 190-cell
stage is depicted for
wild type in A, and
hypothetical lineages
are depicted for pie-
1(zu154) in B and mex-
3(zu155); skn-1(RNAi)
in C. Lineages specified
by SKN-1 and PAL-1
are blue and red,
respectively, and the
pattern of cell fates
produced is indicated
below the wild-type
lineage in A. (D) Approximate fraction of the embryo with different lineage identities for each genotype, with expected changes in transcript
abundance for lineage-specific genes in parentheses.
wild-typeA B pie-1(zu154)
mex-3(zu155) ; skn-1(RNAi)C
wild-type mex-3(zu155);
skn-1(RNAi
0 (0x)
0 (0x)
15/16 (5x)
1/16 (1x)
pie-1(zu154)
1/2 (1x)
1/2 (2x)
0 (0x)
0 (0x)
Ab 1/2 (1x)
EMS 1/4 (1x)
C or D 3/16 (1x)
P 1/16 (1x)
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anteroposterior axis of the embryo for a total of thirty projections.
Dorsal and lateral projections are presented in Fig. 8, and all 30
projections were assembled as a .mov file in Graphic Converter to be
viewed as a movie in Quicktime (see Movies 1-13 in supplementary
material).
Results
Identification of lineage-specific targets of PAL-1
We have previously analyzed transcript abundance in precisely
staged embryos, roughly two time points per cell cycle from
the one-cell stage to mid-gastrulation (190-cell stage), using
custom synthesized high-density oligonucleotide microarrays
(Baugh et al., 2003). Because these wild-type data represent
the baseline for all subsequent comparisons, we re-hybridized
these published samples to commercially available microarrays
used for our current analysis and also by other members of the
C. elegans community. The data are marginally improved by
hybridization to the newer microarrays (lower coefficient of
variation), and in general they are in very good agreement with
their published counterpart. The overall correlation coefficient
comparing the previously published data with that resulting
from re-hybridization to the commercial microarray is 0.90.
The differences observed tend to be small in magnitude and
distributed over many genes (data not shown), though there are
exceptions (including end-3). Because the precision and
density of sampled time points in the wild-type data greatly
increased sensitivity (Baugh et al., 2003), we collected
multiple replicates at similar time points for the mutant
embryos beginning at the four-cell stage (Fig. 1).
Embryos from homozygous pie-1(zu154) mothers lack pal-
1-dependent C and D blastomeres because the identity of the
P2 blastomere is transformed to that of its somatic sister, EMS
(Fig. 1) (Mello et al., 1992). In the absence of the C and D
lineages, PAL-1 targets, whether direct or indirect, should have
reduced expression in pie-1(zu154) relative to wild type, and
genes that are exclusively expressed in the C or D lineage
should not be detected. A pal-1 mutant could not be used
because maternal activity specifies the C and D fates, and pal-
1(null) mutants are zygotic lethal. We chose to use pie-
1(zu154) rather than pal-1(RNAi) embryos as the mutation
results in higher penetrance than RNAi of pal-1 (data not
shown). pie-1(zu154) embryos contain wild-type levels of
PAL-1, but PAL-1 is unable to specify C-lineage identity
because, in the absence of PIE-1 function, SKN-1 dominantly
controls the development of the P2 lineage (Hunter and
Kenyon, 1996). To be certain that the PAL-1 protein present in
pie-1 mutant embryos does not affect transcript abundance, we
measured transcript abundance in parallel in pie-1(zu154); pal-
1(RNAi) embryos. However, the results from the two genotypes
were indistinguishable, indicating that PAL-1 is impotent in the
pie-1(zu154) embryos (data not shown). The aggregate pie-
1(zu154) and pie-1(zu154); pal-1(RNAi) replicates are
combined in the pie-1(zu154) data we report.
Embryos from homozygous mex-3(zu155) mothers translate
pal-1 mRNA throughout the embryo, transforming the eight
great-granddaughters of the AB blastomere into C-like
blastomeres (Fig. 1) (Draper et al., 1996). These eight anterior
blastomeres, born at approximately the same time as the C
blastomere, produce eight serially homologous lineages giving
rise to the muscle and epidermal cell types characteristic of the
C lineage. This transformation requires pal-1 function (Hunter
and Kenyon, 1996), thus expression of PAL-1 targets should
be greater in mex-3(zu155) than in wild type. To sensitize our
ability to detect PAL-1 targets further, skn-1 RNAi was also
used in the mex-3(zu155) background, because, in the absence
of skn-1 function, PAL-1 is active in the EMS lineage
transforming its daughters into C-like blastomeres (Bowerman
et al., 1992; Hunter and Kenyon, 1996).
To test the feasibility of using mutants to deconvolve
lineage-specific patterns of gene expression and to develop
computational rules to enrich for lineage-specific transcripts,
we analyzed a known, skn-1-dependent lineage-specific
transcriptional cascade. In contrast to PAL-1 targets (genes
regulated directly or indirectly by PAL-1), SKN-1 targets
should be more abundant in pie-1(zu154) and less abundant in
mex-3(zu155); skn-1(RNAi) (Fig. 1). SKN-1 directly activates
its earliest zygotic targets, the redundant GATA transcription
factors med-1 and med-2, in the EMS blastomere, initiating a
transcriptional cascade resulting in expression of new genes
after each cell division (Maduro, 2001; Maduro and Rothman,
2002). med-1 and med-2 activate the expression of two more
Development 132 (8) Research article
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Fig. 2. A skn-1-dependent transcriptional cascade. (A) Published expression patterns and regulatory relationships for four transcription factors
and a differentiation gene involved in endoderm development. (B) Temporal expression patterns in wild type, pie-1(zu154) and mex-3(zu155);
skn-1(RNAi) measured by microarray. med-1 and med-2 cannot be distinguished on the microarray.
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GATA factors, end-1 and end-3, specifically in the E lineage,
which activate another GATA factor, elt-2, that activates the
expression of the gut esterase gene ges-1 (Fig. 2). med-1 and
med-2 are expressed at too low abundance to detect
quantitatively in wild type (Baugh et
al., 2003), but they show an expected
increase in pie-1(zu154) at 23 minutes
(eight-cell stage). end-1 transcripts are
about 1.5-fold more abundant in pie-
1(zu154) and are not detected
following skn-1 RNAi. Although end-
3, elt-2 and ges-1 are not detected at
increased abundance in pie-1(zu154),
all three are not detected following
skn-1 RNAi. These observations
indicate that skn-1(RNAi) appears to
phenocopy a null mutant with
respect to target gene expression.
Furthermore, the times of activation
and maximum expression of the skn-1
target genes are equivalent in the
mutants and wild type, suggesting that
the transformed lineage is developing
at the same molecular rate as its native
sister. However, the fact that only end-1 shows elevated
expression in pie-1(zu154) indicates that few target genes will
behave as expected and that we must use flexible rules to
identify candidate PAL-1 target genes.
To identify candidate PAL-1 target genes, we filtered the
data by cluster analysis, a model-directed approach based on
analysis of variance (ANOVA) and expression correlation to
known targets. In order to maximize identification of true PAL-
1 targets, we combined all three approaches, complementing
the biases of each. In order to accommodate the resulting high
false-positive rate, we assigned a cumulative numerical score
from zero to seven for all genes (see Materials and methods)
so that strong candidates can be discerned from weak ones.
Genes scoring one or higher are considered candidate PAL-1
targets, of which 308 were identified. A score of one indicates
that the gene appears to be a target by only one of the three
analytical approaches, while a score of seven indicates that a
gene appears to be a target by all three approaches. The
distribution of scores for candidate target genes is highly
skewed, with nearly half of them (146) scoring one and only
17 scoring five or greater (Fig. 3). Hierarchical clustering of
expression patterns for the 308 candidate targets shows that
expression is generally lower in pie-1(zu154) and greater in
mex-3(zu155); skn-1(RNAi), and it reveals distinct patterns
across time and genotype (Fig. 3), consistent with PAL-1
targets being expressed in diverse spatial patterns and encoding
a variety of developmental functions.
Validation of PAL-1 targets
We expect PAL-1 targets to be expressed in complex
expression patterns, some of which may correlate with the C-
lineage and or muscle or epidermal cell fates. The summary of
expectations given in Fig. 1D is for truly lineage-specific
genes. Because of secondary and confounded effects of the
homeotic transformations used to identify candidate targets
genes, true targets may not have received high scores and many
false targets likely received low scores. To validate select
candidates, we used ‘reporter analysis’ to determine
approximately where each candidate target is expressed and
whether that expression is appropriately responsive to a lack
[pal-1(RNAi)] or excess [mex-3(RNAi)] of pal-1 activity. For
B
A
Fig. 3. Identification and rank of candidate PAL-1 target genes.
(A) A log-scale histogram of the number of genes versus cumulative
scores (1-7) from three distinct tests designed to capture a large
fraction of candidate PAL-1 target genes (see text, and Materials and
methods for details). (B) Hierarchical clustergram for 308 candidate
genes; yellow indicates high and blue low relative expression. The
three time courses were concatenated end to end for hierarchical
clustering but are separated here for clarity.
Fig. 4. Target validation. Embryonic expression of pal-1, assayed by YFP reporter, is dependent
on maternal PAL-1 activity. (A-C) Expression of a zygotic pal-1 reporter is shown in a mid-
gastrula embryo with corresponding Nomarski images for wild-type (A,D), pal-1(RNAi) (B,E)
and mex-3(RNAi) (C,F).
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example, pal-1 received a moderate target score of three, and
maternal PAL-1 has been suspected to activate the transcription
of zygotic pal-1 (Hunter and Kenyon, 1996). We find that a
pal-1 promoter::YFP fusion is expressed exclusively in the C
and D lineage of early wild-type embryos, but is not detected
in pal-1(RNAi) embryos, and is expressed ectopically in the
anterior of mex-3(RNAi) embryos (Fig. 4). Because this
reporter contains no pal-1-coding sequence, RNAi of pal-1
does not directly effect reporter expression, but only the
endogenous gene. This result demonstrates that maternal pal-
1 activates zygotic pal-1 expression and suggests that zygotic
pal-1 auto-regulates its expression.
We analyzed 39 candidate target genes by reporter analysis
in wild type and following pal-1 and mex-3 RNAi (Table 1).
Among the 308 unique candidate target genes, all predicted
transcription factors or signaling molecules were selected for
the reporter assay, as well as a random eight out of 17 high-
scoring genes (scored as five or greater). Expression was
detected for 31 (79%) of the reporters and 21 (68%) of those
were confirmed as targets, with those scoring higher in the
cumulative index validating more frequently (Table 2).
Temporal expression profiles for each of the validated targets
can be found in Fig. S2 in the supplementary material. Failure
to be validated does not necessarily mean that the gene is not
a target as there are multiple reasons why the reporter assay
may result in false negatives. Nevertheless, the validation
efficiency suggests that roughly 130 of the 308 candidates
would be validated by this reporter assay.
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Table 1. Results of target validation
Target Promoter pal-1 mex-3
ORF Gene score size (kb) Wild-type expression pattern (RNAi) (RNAi) Target
C28C12.7 spp-10 7 1.7 C lineage NE EE Yes
F01F1.6 7 0.3 No expression ND ND No
R02D3.1 7 0.8 C lineage NE EE Yes
K10B4.6 cwn-1 6 1.9 Posterior C lineage NE EE Yes
B0304.1 hlh-1 6 3.0 Muscle NPE EE Yes
C09D4.2 5 0.8 C lineage NE EE Yes
C46H11.2 5 2.1 C epidermis NE EE Yes
R07C3.11 5 1.1 Epidermis LE EE Yes
T22B7.3 5 1.8 C epidermis then more epidermis NE EE Yes
ZK1307.1 5 1.1 C epidermis NE EE Yes
C55C2.1 4 6.1 C and D muscle (left side) NE EE Yes
F20D1.4 4 0.4 No expression NE NE No
F45E4.2 plp-1 4 1.1 No expression NE NE No
F23H12.4 sqt-3 4 2.0 C epidermis then more epidermis EE EE Maybe
ZK829.4 4 0.6 No expression NE NE No
T07C4.6 tbx-9 3 3.8 C and AB epidermis, MS NPE EE Yes
C38D4.6 pal-1 3 1.4 C and D lineage NE EE Yes
C54F6.8 3 5.0 Epidermis LE EE Yes
D1081.2 unc-120 3 5.0 Muscle NPE EE Yes
F35D2.3 3 5.0 Many cells ND ND No
C32F10.5 hmg-3 3 5.0 No expression NE NE No
C44C10.8 hnd-1 3 1.5 Muscle* NPE EE Yes
Y75B8A.2 nob-1 3 4.9 Posterior epidermis and posterior E LE EE Yes
C32E8.8 ptr-2 3 3.0 Too dim to score EE EE No
T07C4.2 tbx-8 2 3.8 C and AB epidermis, MS NPE EE Yes
ZK270.1 ptr-23 2 5.0 C epidermis then all epidermis EE ND No
F35G12.6 mab-21 2 4.7 C and AB epidermis NPE EE Yes
W09C2.1 elt-1 1 NA Epidermis† Unk Unk Probably
M142.4 vab-7 1 13.8 Posterior C lineage NE EE Yes
T27B1.2 1 5.0 Epidermis ND EE Maybe
F57A10.5 nhr-60 1 2.0 Epidermis ND EE Maybe
F11C1.6 nhr-25 1 5.0 Epidermis‡ NPE ND Yes
F18A1.2 lin-26 1 0.8 C epidermis then all epidermis ND ND No
F45E4.9 hmg-5 1 0.3 Late epidermis ND ND No
K02B9.4 elt-3 1 4.9 Non-seam epidermis LE EE Yes
C13G5.1 ceh-16 1 4.1 No expression ND ND No
C30G4.3 gcy-11 1 3.2 No expression NE NE No
C25G6.5 1 4.4 Too dim to score EE ND No
W03D2.5 wrt-5 1 0.8 No expression ND ND No
Y71F9AL.17 1 0.4 Late epidermis ND ND No
Thirty-nine genes were selected from the list of 308 candidate targets for validation by the assay presented in Fig. 4. Genes were selected either because they
have high candidate target scores, they are predicted to be involved in transcription or signaling, or they have known developmental phenotypes.
NE, no expression; NPE, no posterior expression; LE, less expression; EE, ectopic expression; ND, no difference from wild type; Unk, not determined.
Expression in the C and D lineages was not distinguished. Additional, relatively rare expression may not be reported. Results are for early embryo (~4 hours)
only (i.e. where ‘No expression’ is reported). 
*Data for hnd-1 expression were obtained with JK3363 (Mathies et al., 2003). 
†We were unable to establish elt-1::yfp reporter lines (consistent with B. Page’s rescue experiments) and therefore rely on the published expression pattern
(Page et al., 1997). 
‡nhr-25 is reported to be expressed in the posterior epidermis but also the endoderm (Asahina et al., 2000); however, we do not see endodermal expression with
either the published strain or ours.
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Lineage-based regulation of tissue identity genes
With the exception of intestine and germline, cell fates in the
C. elegans embryo are polyclonal (Sulston et al., 1983).
Nevertheless, precursor cells for a given tissue or organ are
typically born near each other such that a fate map can be
drawn for the mid-gastrula embryo. It has been suggested that
this regional positioning of tissue and organ precursors enables
their coherent development as tissue and organ primordia
(Labouesse and Mango, 1999). However, it is not known what
mechanisms direct the expression of tissue and organ identity
genes in the appropriate cells. It is possible that the position of
a cell in the embryo could influence the decision to express a
given tissue identity gene (Schnabel, 1996). Alternatively,
different cell-autonomous mechanisms could direct the
expression of the tissue identity gene in different lineages.
The muscle-specific genes hnd-1, hlh-1 and unc-120 are
expressed in muscle precursors in the MS, C and D lineages
(Krause et al., 1990; Mathies et al., 2003) (Fig. 5, Fig. 8).
Although the expressing cells are derived from three lineages,
they are born in the ventral-posterior region of the embryo and
within two cell divisions form four longitudinal stripes pre-
ordaining the four quadrants of body wall muscle present at
hatching (Fig. 5, Fig. 8). To determine if the decision to express
these tissue identity genes is controlled in a cell-autonomous
fashion, we examined reporter gene expression more carefully
following RNAi of pal-1. Consistent with a lineage-based
mechanism, pal-1 function is required for expression of hnd-
1, hlh-1 and unc-120 reporter genes in the C and D lineages
but not MS (Fig. 5), where we presume an unknown lineage-
specific factor is required for their expression.
Regulation of a posterior HOX gene in lineage-
specific fashion
pal-1, also known as nob-2, was isolated from the same
forward genetic screen as the Abd-b/Hox9-13 ortholog nob-1
(Van Auken et al., 2000). The Nob (no back end) phenotype
suggests that the two genes may function in a common pathway
to pattern posterior development. Consistent with this
hypothesis, a transcriptional reporter for nob-1 is expressed in
the extreme posterior of the embryo in cells derived from the
AB, E and C lineages (see Figs 7 and 9). This expression
pattern suggests regional, as opposed to lineage-based,
regulation of nob-1 because regional regulation need only
require a single mechanism, while lineage-based regulation
would require nob-1 expression to be activated independently
in the most posterior descendants of each lineage. We find that
expression of a nob-1 reporter within the C lineage requires
pal-1 function and that mex-3(RNAi) results in ectopic anterior
expression of nob-1::YFP in a relatively small number of cells
consistent with nob-1 being expressed in one-eighth of the C
lineage (Fig. 6). These results indicate that nob-1 expression
in the C lineage requires lineage-specific pal-1-dependent
information, although we cannot rule out the possibility that
nob-1 expression requires pal-1-dependent signaling activity.
However, given that in pal-1(RNAi) embryos nob-1::YFP is
expressed in the AB and E lineages and that in mex-3(RNAi)
embryos nob-1::YFP is expressed in sparse pairs of anterior
cells, it is unlikely that nob-1 expression is activated by a pal-
1-dependent signaling activity.
PAL-1 targets affect specification, differentiation and
morphogenesis of C-lineage cells
Candidate PAL-1 targets selected for validation by reporter
gene analysis were biased toward potential developmental
regulators (Table 3). Twelve transcription factors representing
many families, including homeodomain, zinc-finger, GATA,
MADS domain, bHLH and T-box are included, consistent with
PAL-1 targets controlling diverse aspects of development. That
so many previously characterized transcription factors are
among the targets of PAL-1 suggests that pal-1 controls a
transcriptional regulatory network.
To begin to dissect the function and regulatory relationships
among the validated PAL-1 targets, we measured embryonic
lethality following RNAi by soaking. Given the pleiotropy and
Table 2. Efficiency of target validation
Number Number 
Target score of genes tested by reporter Expression detected Validated as target Validation efficiency
5, 6 or 7 17 10 9 9 90%
2, 3 or 4 145 17 13 9 53%
1 146 12 9 3 25%
All 308 39 31 21 54%
Only genes with a ‘yes’ in Table 1 are included in the percentage.
Fig. 5. Reporters for muscle-specific
transcription factors are regulated in a lineage-
specific fashion. Expression of hnd-
1::GFP::lacZ (A,D), hlh-1::YFP (B,E) and
unc-120::YFP (C,F) in wild-type (A-C) and
pal-1(RNAi) (D-F) embryos. pal-1 RNAi
eliminates expression in the C and D lineages
(posterior). hnd-1::gfp::lacZ embryos were
imaged 210 minutes after the four-cell stage
and hlh-1::yfp and unc-120::yfp at 260 minutes
(22°C). Because of the larger size of the
reporter protein the signal for hnd-1::gfp::lacZ
is better localized to the nucleus than in the
other two strains.
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severity of pal-1 loss-of-function phenotypes, we were
surprised that RNAi of only two of the 22 genes resulted in
100% embryonic lethality (pal-1 and elt-1), while another two
resulted in significant lethality (hlh-1 and nob-1) (Table 3). The
embryonic function of these four genes has been described in
the literature, and they affect specification, differentiation or
morphogenesis of C-lineage cells. Zygotic pal-1 function is
required for proper morphogenesis of the C lineage (Edgar et
al., 2001), elt-1 is required for specification of the epidermis
(Page et al., 1997), hlh-1 is required for differentiation of the
muscle (Chen et al., 1994) and nob-1 is required for
morphogenesis of the posterior epidermis (Van Auken et al.,
2000). RNAi of several of the other genes produced post-
embryonic phenotypes indicative of a function in posterior
morphogenesis. For example, tail defects in larvae lacking vab-
7, pal-1, nob-1, tbx-8 and tbx-9 function have been shown to
result from improper morphogenesis of C-lineage cells
(Ahringer, 1996; Edgar et al., 2001; Pocock et al., 2004; Van
Auken et al., 2000), and the rare larval defects seen following
loss of function of hnd-1, nhr-25 and cwn-1 are also likely to
result in part from improper morphogenesis of C-lineage cells
(Table 3). Although additional subtle phenotypes may be
detected in more sensitive phenotypic assays, the limited
number of penetrant phenotypes following RNAi may be
attributable to ineffective depletion by RNAi, functional
redundancy of individual genes or network level compensatory
mechanisms.
Predicting regulatory network structure from
expression
To model the regulatory network specified by PAL-1, we
focused on the expression patterns of validated targets most
Development 132 (8) Research article
Fig. 6. Expression of the posterior
HOX gene nob-1 is regulated by cell
lineage. (A) Wild-type expression of
a nob-1 YFP reporter in a ~200-cell
embryo (210 minutes after the four-
cell stage at 22°C). Arrows indicate
the two posterior-most C-lineage
cells. Expression of the nob-1
reporter in similarly staged pal-
1(RNAi) (B) and mex-3(RNAi) (C)
embryos shows loss of and ectopic expression, respectively.
Table 3. Phenotypic analysis of validated target genes
Published Embryonic 
ORF Gene Identification RNAi* lethality (n) Embryonic function Larval phenotype
C28C12.7 spp-10 Predicted prosaposin Wild type 1% (787)
R02D3.1 Dehydrogenase Wild type 0% (731)
C09D4.2 Uncharacterized Wild type 2% (657)
C38D4.6 pal-1 Homeobox transcription factor Emb 100% (1038) Specification and Nob, Vab‡
(cad subfamily) morphogenesis of 
C lineage†,‡
M142.4 vab-7 Homeobox TF (even-skipped subfamily) Bmd 2% (512) Morphogenesis of C Nob, Vab§
lineage§
C55C2.1 Zinc-finger transcription factor Wild type 2% (1032)
B0304.1 hlh-1 bHLH transcription factor Wild type 9% (716) Differentiation of muscle¶ Unc¶
D1081.2 unc-120 MADS domain transcription factor Unc 3% (680) Differentiation of muscle** Unc**
C44C10.8 hnd-1 Hand bHLH transcription factor Bmd 1% (516) Posterior bulges***
K10B4.6 cwn-1 Putative wingless ligand NA 2% (507) Rare tail defects†††
R07C3.11 Uncharacterized Wild type 1% (699)
C54F6.8 Nuclear hormone receptor Wild type 2% (875)
F11C1.6 nhr-25 Nuclear hormone receptor Wild type 1% (718) Rare tail defects‡‡
W09C2.1 elt-1 GATA transcription factor Emb, Unc 100% (487) Specification of epidermis††
K02B9.4 elt-3 GATA transcription factor Wild type 1% (833)
F35G12.6 mab-21 Highly conserved novel protein Wild type 2% (711) Sqt, male tale 
defects§§
T22B7.3 Uncharacterized Wild type 1% (657)
C46H11.2 Uncharacterized Wild type 1% (791)
ZK1307.1 Uncharacterized Wild type 1% (698)
T07C4.2 tbx-8 T-box transcription factor (Brachyury) Wild type 3% (502) Vab, posterior bulges, 
tail defects†††
T07C4.6 tbx-9 T-box transcription factor (Brachyury) Wild type 1% (520) Vab, posterior bulges, 
tail defects†††
Y75B8A.2 nob-1 Homeodomain transcription factor Emb, Bmd 36% (761) Morphogenesis of posterior Nob, Vab¶¶
(posterior Hox paralog) epidermis¶¶
Protein identification, published phenotypes from a genome-wide RNAi screen, embryonic lethality following RNAi, and known embryonic functions and
larval phenotypes are summarized. 
Emb, embryonic lethal; Bmd, body morphology defective; Unc, uncoordinated; Nob, no back end; Vab, variably abnormal morphogenesis; Sqt, squat.
*Kamath and Ahringer, 2003; †Hunter and Kenyon, 1996; ‡Edgar et al., 2001; §Ahringer, 1996; ¶Chen et al., 1994; **Williams and Waterston, 1994; ††Page et
al., 1997; ‡‡Asahina et al., 2000; §§Chow et al., 1995; ¶¶Van Auken et al., 2000; ***Mathies et al., 2003; †††This work (data not shown). 
Published RNAi results are only shown for Emb, Bmd and Unc only (wild type only relates to those three phenotypes).
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likely to directly effect gene expression. This includes 12
transcription factors, an uncharacterized wingless ligand (cwn-
1) and a conserved novel protein known to affect cell fate
decisions in the male tail (mab-21). Global analysis of
transcript abundance in wild-type embryos has shown
that most temporally modulated embryonic genes are
expressed transiently, with abundance increasing for
one cell cycle and decreasing for one after that (Baugh
et al., 2003), consistent with the timing of gene
expression during specification of endodermal cell fate
(Maduro and Rothman, 2002). The first three divisions
of the C blastomere are asymmetric in either cell fate
or gene expression (Ahringer, 1996; Sulston et al.,
1983), suggesting that the PAL-1 network may also
operate on a one cell cycle time scale. Consistent with
this expectation, transcription of these target genes is
activated in one of four temporal phases, each a cell
cycle apart (Fig. 7). Twelve out of the 14 selected
targets are expressed in two waves corresponding to
the 4C-cell stage (phase II) and the 8C-cell stage
(phase III). mab-21 is the only phase IV gene among
the 14, and pal-1 is considered phase I because its
zygotic transcripts are first detected by in situ
hybridization at the 2C-cell stage in Ca and Cp
(Hunter and Kenyon, 1996).
To generate a working model of the regulatory
network, we began with the simple notion that targets
from one phase regulate targets of the next, with
transcription factors regulating targets expressed in the
same cells and signaling molecules regulating targets
in adjacent cells from where each is expressed. As
YFP expression perdures, we compared spatial
expression patterns of each target at the end of phase IV,
capturing the spatial expression patterns initiated earlier. Fig.
8 shows dorsal and lateral views of volume rendered images
4 C 8 C 16 C2 C
phase II
phase III
phase IV
phase I
Fig. 7. PAL-1 target genes likely involved in patterning are expressed in four
temporal phases. Wild-type temporal expression patterns are plotted for 13
validated target genes that encode 11 transcription factors, a wingless ligand
(cwn-1) and a novel protein (mab-21) known to be involved in a cell fate
switch in the male tail. Developmental stages are indicated as the number of C-
lineage cells across the top of the graph, and the phase each gene belongs to is
indicated by color (based on when zygotic expression is first detected). vab-7
is omitted from the graph because it is not detected in wild type by microarray,
but we know it is a phase II gene based on lacZ reporter and in situ
hybridization (Ahringer, 1996), as well as its detection in the mex-3(zu155);
skn-1(RNAi) timecourse data.
Fig. 8. Projection of three-dimensional images of reporter expression patterns for PAL-1 target genes likely to be involved in patterning. Dorsal
and lateral views of chromosomally integrated transcriptional reporters 210 minutes after the four-cell stage (22°C; ~200 cells, 16 C-lineage
cells) are shown for 13 validated targets. Images are orthogonal perspectives following three-dimensional volume rendering of many optical
sections. A broken gray line marks the approximate outline of each egg case. (A) Ordination: 8 C ectodermal nuclei in blue, 8 C muscle nuclei
in red and 4 D muscle nuclei in yellow; (B) pal-1; (C) vab-7; (D) cwn-1; (E) C55C2.1; (F) unc-120; (G) hnd-1; (H) hlh-1; (I) elt-3; (J) mab-21;
(K) nhr-25; (L) nob-1; (M) tbx-8; (N) tbx-9. Movies for each reporter are available in the supplementary material.
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of transcriptional reporters (see also Movies 1-13 in the
supplementary material). The expression patterns are
summarized in Table 4, and are consistent with published
descriptions. hnd-1, hlh-1 and unc-120 are expressed in all of
the embryonic myoblasts, but hnd-1 is phase II and hlh-1 and
unc-120 are phase III, suggesting that hnd-1 is a positive
regulator of hlh-1 and unc-120. We have extended this logic,
combining spatial expression with quantitative temporal data
to identify the best candidate upstream activator for each of the
14 target genes (Table 4). This set of predictions provides a
first draft model of the transcriptional network specified by
PAL-1 in the C lineage (Fig. 9). Expression of all fourteen
targets is by definition dependent on pal-1 function, and we
presume that both maternal and zygotic PAL-1 act directly on
phase II targets, but we do not know if PAL-1 acts directly on
phase III or IV targets. The model predicts which phase II
targets activate which phase III targets, as well as the activation
of the phase IV target mab-21 by the phase III target elt-3, and
it can easily be extended for other validated targets.
Discussion
We have shown that lineage-specific patterns of gene
expression can be deconvolved from microarray data collected
from whole C. elegans embryos by analyzing mutants with
transformed lineage identity (Figs 2, 3). This approach can be
extended with available mutants to identify
genes specifically expressed in each of the
somatic founder lineages of the embryo.
Although reporter genes will eventually be
made for the entire genome, scoring all of their
embryonic expression patterns will be
difficult. By contrast, microarrays can be used
to predict the early embryonic expression
pattern for each gene in the genome and
reporters can be used for validation and
refinement.
The identification of PAL-1 targets confirms
previous phenotypic analysis (Hunter and
Kenyon, 1996) by demonstrating that it
controls development of the C lineage,
including specification of multiple cell types.
PAL-1 activates expression of target genes
responsible for various developmental
functions such that their disruption
phenocopies different aspects of the pal-1
mutant phenotype (Table 3). Although many
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Table 4. A simple model for predicting regulatory relationships from temporal and spatial expression patterns
Temporal Best candidate 
Gene phase Spatial expression pattern Supporting data Refs upstream activator
pal-1 I 16 C, 4 D Reporter, antibody, in Edgar et al., 2001; Hunter pal-1
situ hybridization and Kenyon, 1996
cwn-1 II C and D muscle, 2 posterior C ectoderm pal-1
C55C2.1 II Left posterior muscle (C and D), unidentified pal-1
ventral cells
hnd-1 II All muscle (including 8 C muscle, 4 D muscle) Reporter Mathies et al., 2003 pal-1
tbx-8 II Dorsal epidermis, unidentified lateral cells Reporter Pocock et al., 2004; Andachi, pal-1
(including 8 C ectoderm) 2004
tbx-9 II Dorsal epidermis, unidentified lateral cells Reporter, in situ Pocock et al., 2004; Andachi, pal-1
(including 8 C ectoderm) hybridization 2004
elt-1 II All major epidermis Antibody Page et al., 1997 pal-1
vab-7 III 8 C: four posterior muscle, four posterior Reporter, in situ Ahringer 1996 cwn-1
ectoderm hybridization
unc-120 III All muscle (including 8 C muscle, 4 D muscle) Reporter Waterston (unpublished) hnd-1
hlh-1 III All muscle (including 8 C muscle, 4 D muscle)* Reporter, antibody, in Krause et al., 1990; Seydoux and hnd-1
situ hybridization Fire, 1994
elt-3 III Non-seam major epidermis (including 8 C Reporter Gilleard et al., 1999 elt-1
ectoderm)
nhr-25 III Dorsal epidermis (including 8 C ectoderm) Reporter Asahina et al., 2000 elt-1
nob-1 III Posterior endoderm (E) and ectoderm – mostly In situ hybridization Kohara (unpublished) cwn-1
non-C
mab-21 IV Dorsal-most epidermis (including 8 C ectoderm) Reporter Ho et al., 2001 elt-3
Temporal phase and spatial expression pattern are summarized for 14 target genes likely to be involved in patterning. The best candidate upstream activator for
each gene is the gene from the previous temporal phase with the most similar spatial expression pattern. References with supporting data measured by a variety of
techniques are included where available. All reporter expression patterns are consistent with published data. *Expression is seen only in posterior muscle (C and
D), where it is initiated (see Fig. 7).
pal-1 m
pal-1 zphase I
phase II
phase III
phase IV
tbx-8
tbx-9
elt-1
elt-3
mab-21
nhr-25
hnd-1 C55C2.1
unc-120 hlh-1
cwn-1
vab-7nob-1
C lineage
C ectoderm C muscle
Fig. 9. Proposed structure of the regulatory network specified by pal-1. A graph of
predicted regulatory relationships based on the best candidate upstream activator for
each gene (Table 4) is presented. Temporal phase is indicated on the left. Lines with
arrows represent cell-autonomous regulation by transcription factors and lines with dots
represent regulation by signaling molecules.
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of the target genes function in the descendants of additional
founder blastomeres, their expression in the C lineage depends
on PAL-1 (Table 1). We specifically show three muscle-specific
genes to require pal-1 function for C-lineage expression (Fig.
5) and find the same to be true for epidermis-specific
expression (Table 1). If specification of cell fate were
controlled by regionalizing influences as opposed to lineage-
based mechanisms, we would not expect expression of fate-
specific genes to depend on pal-1 function (unless pal-1 were
required to respond to regionalizing influences). Furthermore,
expression of the posterior HOX gene nob-1 is complex with
respect to lineage but simple with respect to region, yet we
show that nob-1::YFP expression in the C lineage requires
PAL-1.
We propose a model for the structure of the network
specified by PAL-1 based only on temporal and spatial
expression patterns in wild type (Fig. 9). The rationale behind
the model is simple: genes activated in one cell cycle affect the
expression of genes expressed in the next cell cycle. This
premise is supported by both functional analysis of the
endodermal network (Maduro and Rothman, 2002) and global
analysis of expression dynamics (Baugh et al., 2003).
Furthermore, whereas zygotic pal-1 transcripts are first
detected at the 2C-cell stage in Ca and Cp (phase I), loss of
zygotic pal-1 function results in a detectable mutant phenotype
in their daughters at the 4C-cell stage (Edgar et al., 2001;
Hunter and Kenyon, 1996). In addition, protein for the phase
II gene elt-1 is first detected at the end of the 4C-cell stage,
and transcription of its confirmed phase III target elt-3 begins
in the 8C-cell stage (Fig. 7) (Gilleard and McGhee, 2001; Page
et al., 1997).
That ectopic PAL-1 activity in early blastomeres is sufficient
to cause complete transformation of one lineage into another
indicates that the regulatory network specified by PAL-1 is
modular or self-contained (Draper et al., 1996; Hunter and
Kenyon, 1996). After maternal PAL-1 specifies the C lineage,
embryonically expressed PAL-1 is required for C-lineage
development (Edgar et al., 2001). We therefore hypothesize
that PAL-1 continuously regulates target genes during
patterning of the C lineage, as opposed to simply initiating a
transcriptional cascade. Although it is not known how far into
development PAL-1 function is required, phenotypically
mutant pal-1 mosaic animals were recovered corresponding to
loss of pal-1 in one Cxx cell at the 4C-cell stage and PAL-1
expression is detectable in the C lineage until the 16C-cell
stage (Edgar et al., 2001), leaving open the possibility that
PAL-1 directly activates each of the target genes identified
here. Combinatorial control of gene expression, where early
targets regulate late targets in combination with PAL-1, offers
one possible mechanism for the timing of gene expression
within this modular network (Mangan and Alon, 2003; Penn
et al., 2004).
There must be additional regulation not predicted by our
model. Genes that are not PAL-1 targets are likely to participate
in transcriptional regulation and patterning of the C lineage.
For example, the Homothorax ortholog unc-62 and the
Extradenticle homologs ceh-20 and ceh-40 have superficially
similar phenotypes to nob-1 and pal-1, suggesting that these
co-factor homeodomain proteins interact with and modify the
function of PAL-1 and NOB-1 (Van Auken et al., 2002).
Likewise, the Tcf/Lef factor pop-1 is thought to mediate cell-
fate decisions associated with every cell division on the AP axis
of the early embryo (Lin et al., 1998), and, as has been shown
for development of the E lineage (Calvo et al., 2001; Maduro
et al., 2002), we expect POP-1 to contribute to patterning of
PAL-1 target expression, in particular where targets are
expressed in only the anterior or posterior daughters following
a round of C cell divisions (e.g. hlh-1, elt-1 and vab-7).
Repression is completely ignored in the current model, but is
probably crucial for patterning, as indicated by the fact that
very few targets are expressed in all PAL-1-expressing cells.
So there may also be genes repressed by PAL-1. We have not
allowed for genes of the same temporal phase to regulate each
other, though it is likely that there is mutual repression between
genes specifying muscle and epidermis, leading to insulation
of the two states. In addition, genes of the same temporal phase
expressed in the same cells may activate the expression of one
another, and we imagine multiple auto-regulatory positive
feedbacks in addition to the one demonstrated for pal-1. It
will be interesting to compare the structures of different
developmental regulatory networks in an effort to understand
better how different topological motifs contribute to the
functional properties of the regulatory network (Milo et al.,
2002; Shen-Orr et al., 2002) and ultimately how network
structure relates to body plan.
Strain JK3363 was kindly provided by Judith Kimble. We thank
Shai Shen-Orr for bioinformatics support. This work was funded by
an NIH GM64429 to C.P.H.
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